EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders

Irina Balan iD, Giorgia Boero iD, Samantha Lucenell Chéry, Minna H McFarland, Alejandro G Lopez iD, A Leslie Morrow iD

Life · 30.04.2024 · 14 (5) · 582

DOI: 10.3390/life14050582 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 30.04.2024. Verfasst von Irina Balan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bowles Center for Alcohol Studies, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 558 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIH, Bowles Center for Alcohol Studies at the UNC School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnane neuroactive steroids, notably allopregnanolone and pregnenolone, exhibit efficacy in mitigating inflammatory signals triggered by toll-like receptor (TLR) activation, thus attenuating the production of inflammatory factors. Clinical studies highlight their therapeutic potential, particularly in conditions like postpartum depression (PPD), where the FDA-approved compound brexanolone, an intravenous formulation of allopregnanolone, effectively suppresses TLR-mediated inflammatory pathways, predicting symptom improvement. Additionally, pregnane neurosteroids exhibit trophic and anti-inflammatory properties, stimulating the production of vital trophic proteins and anti-inflammatory factors. Androstane neuroactive steroids, including estrogens and androgens, along with dehydroepiandrosterone (DHEA), display diverse effects on TLR expression and activation. Notably, androstenediol (ADIOL), an androstane neurosteroid, emerges as a potent anti-inflammatory agent, promising for therapeutic interventions. The dysregulation of immune responses via TLR signaling alongside reduced levels of endogenous neurosteroids significantly contributes to symptom severity across various neuropsychiatric disorders. Neuroactive steroids, such as allopregnanolone, demonstrate efficacy in alleviating symptoms of various neuropsychiatric disorders and modulating neuroimmune responses, offering potential intervention avenues. This review emphasizes the significant therapeutic potential of neuroactive steroids in modulating TLR signaling pathways, particularly in addressing inflammatory processes associated with neuropsychiatric disorders. It advances our understanding of the complex interplay between neuroactive steroids and immune responses, paving the way for personalized treatment strategies tailored to individual needs and providing insights for future research aimed at unraveling the intricacies of neuropsychiatric disorders.

Schlagwörter

Stichwörter der Autor:innen

allopregnanolonecytokinesinflammationneurosteroidpregnenolone

Autor:innen und Institutionen

  • Bowles Center for Alcohol Studies, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Psychiatry, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
  • Neuroscience Curriculum, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Department of Pharmacology, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

ORCID-Profile: Irina Balan, Giorgia Boero, Alejandro G Lopez, A Leslie Morrow

Förderung

  • NIAAA NIH HHS
  • NIH
  • Bowles Center for Alcohol Studies at the UNC School of Medicine

Zitieren

APA

Balan, I., Boero, G., Chéry, S. L., McFarland, M. H., Lopez, A. G., & Morrow, A. L. (2024). Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders. Life, 14(5), 582. https://doi.org/10.3390/life14050582

Vancouver

Balan I, Boero G, Chéry SL, McFarland MH, Lopez AG, Morrow AL. Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders. Life. 2024;14(5):582. doi:10.3390/life14050582

BibTeX
@article{Balan2024,
  author = {Balan, Irina and Boero, Giorgia and Chéry, Samantha Lucenell and McFarland, Minna H and Lopez, Alejandro G and Morrow, A Leslie},
  title = {Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {582},
  doi = {10.3390/life14050582}
}
Kostenlos starten →